Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03965221 · ClinicalTrials.gov registry record · NA
Comparison of Men's Prevention Apps to Research Efficacy
A NA study, sponsored by Public Health Foundation Enterprises.
- Completed
- Registry status
- NA
- Development phase
- 381
- Enrollment target
NCT03965221: Completed NA study, sponsored by Public Health Foundation Enterprises.
NCT03965221 is a NA study that has completed, run by Public Health Foundation Enterprises. The registered enrollment target is 381 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03965221, a NA study, has completed, sponsored by Public Health Foundation Enterprises.
- COMPLETED
- Registry status
- NA
- Development phase
- 381 participants
- Enrollment target
Study Summary
A randomized three arm control trial to examine the efficacy of two distinct apps (LYNX and MyChoices) developed for young men who have sex with men (YMSM) compared to standard of care (SOC) information about HIV testing and PrEP (Pre-Exposure Prophylaxis).
Primary Outcome
Proportion who complete \>= 1 HIV test
Interventions
- BEHAVIORAL LYNX
- BEHAVIORAL MyChoices
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 381 participants |
| Start Date | 2019-10-14 |
| Est. Completion | 2022-05-31 |
| Phase | NA |
What the finished NCT03965221 record still lists
NCT03965221 is an interventional study that assigns participants to a tested intervention. The registered 381 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which LYNX is the first listed.
NCT03965221 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03965221 about?
NCT03965221 is a clinical study titled "Comparison of Men's Prevention Apps to Research Efficacy". A randomized three arm control trial to examine the efficacy of two distinct apps (LYNX and MyChoices) developed for young men who have sex with men (YMSM) compared to standard of care (SOC) information about HIV testing and PrEP (Pre-Exposure Prophylaxis).
What is the current status of trial NCT03965221?
This trial is currently completed. It is a NA study. The enrollment target is 381 participants. The study started on 2019-10-14. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT03965221?
The interventions under investigation include: LYNX (BEHAVIORAL), MyChoices (BEHAVIORAL).
Who is sponsoring clinical trial NCT03965221?
This trial is sponsored by Public Health Foundation Enterprises, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03965221's enrollment target sits among peer trials
381 273rd of 2000 higher than 1,728 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05677490 · 382 participants · Phase 3
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
- NCT06196008 · 382 participants · NA
Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
- NCT07100990 · 382 participants · Phase 3
Treatment of Inflammatory Myelitis and Optic Neuritis With Early vs Rescue Plasma Exchange (TIMELY-PLEX)
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI